IPOs

Duality plans Hong Kong IPO to fund trials of BioNTech-partnered ADCs and beyond
Fierce Biotech
Tue, 08/27/24 - 11:34 am
DualityBio
China
Hong Kong
IPOs
BioNTech
MBX files for IPO, seeking cash to take challenger to Ascendis' Yorvipath into phase 3
Fierce Biotech
Mon, 08/26/24 - 10:09 am
MBX Biosciences
IPOs
Ascendis Pharma
Yorvipath
Bicara and Zenas file for IPOs to push late-phase prospects toward finish line
Fierce Biotech
Fri, 08/23/24 - 10:57 am
Bicara Therapeutics
Zenas BioPharma
IPOs
Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO
Reuters
Thu, 08/22/24 - 10:01 pm
Zenas BioPharma
IPOs
Bristol Myers Squibb
Cancer-focused Actuate is latest biotech on Nasdaq after $22.4M IPO
Fierce Biotech
Thu, 08/15/24 - 11:48 am
Actuate Therapeutics
IPOs
NASDAQ
Sluggish enrollment leads Boundless Bio to make 'modest' layoffs 5 months after $100M IPO
Fierce Biotech
Tue, 08/13/24 - 11:32 am
Boundless Bio
layoffs
clinical trials
IPOs
BBI-355
OS Therapies refiles IPO for a modest $6M to fund phase 2 HER2 drug, preclinical ADCs
Fierce Biotech
Thu, 08/1/24 - 11:39 am
OS Therapies
IPOs
Biopharma Investment Activity Continued to Rise in Q2: J.P. Morgan
BioSpace
Wed, 07/31/24 - 11:21 pm
biopharma
funding
IPOs
M&A
Private biotech M&A surges amid difficult IPO market
BioPharma Dive
Mon, 07/22/24 - 06:44 pm
M&A
IPOs
Actuate halves upcoming IPO to just $22M, scaling back clinical plans for cancer drug
Fierce Biotech
Mon, 07/22/24 - 11:32 am
Acuate Therapeutics
IPOs
oncology
Artiva prices $167M IPO, riding optimism for autoimmune cell therapy
BioPharma Dive
Fri, 07/19/24 - 11:43 am
Artiva
IPOs
autoimmune disease
​​​​​​​Alumis cuts IPO size, but nets $250M for immune drug work
BioPharma Dive
Fri, 06/28/24 - 11:37 am
Alumis
IPOs
Alumis eyes IPO of over $300M to fund clinical-stage TYK2 pipeline
Fierce Biotech
Mon, 06/24/24 - 10:55 am
Alumis
IPOs
TYK2 inhibitors
ESK-001
Ex-Groupon CEO raises $411 million in IPO for precision medicine data company
Axios
Fri, 06/14/24 - 11:07 am
IPOs
Tempus AI
artificial intelligence
precision medicine
Radiopharma firm Telix abandons Nasdaq listing plans
Pharma Voice
Fri, 06/14/24 - 11:06 am
Telix Pharmaceuticals
radiopharmaceuticals
IPOs
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive
Mon, 06/10/24 - 11:17 am
Alumis
IPOs
funding
Bristol Myers Squibb
Sotyktu
psoriatic arthritis
Third Rock’s Rapport reveals upsized $154M IPO
Fierce Biotech
Fri, 06/7/24 - 11:30 am
Rapport Therapeutics
IPOs
epilepsy
As biotech recovers, venture firms’ preferences appear to shift
BioPharma Dive
Fri, 06/7/24 - 11:26 am
funding
biotech
venture capital
M&A
IPOs
Regenerative cell therapy biotech uses IPO to blast into human trials
Pharma Voice
Wed, 06/5/24 - 11:19 am
FibroBiologics
IPOs
cell therapy
regenerative cell therapy
Radiopharma-focused Telix heats up IPO summer market with $200M offering
Fierce Biotech
Wed, 06/5/24 - 11:13 am
radiopharmaceuticals
IPOs
Telix Pharmaceuticals

Pages